Margaret J. Gunter, PhD

Articles by Margaret J. Gunter, PhD

Colorectal Cancer Screening Use Among Insured Primary Care Patients

ByDeirdre A. Shires, MPH, MSW,George Divine, PhD,Michael Schum, PhD,Margaret J. Gunter, PhD,Dorothy L. Baumer, MS,Danuta Kasprzyk, PhD,Daniel E. Montano, PhD,Judith Lee Smith, PhD,Jennifer Elston Lafata, PhD

July 13th 2011

Colorectal cancer screening use was similar in 2 divergent primary care populations. Colonoscopy was the most frequently used modality; FOBT was used inconsistently.

Monitoring of Drugs With a Narrow Therapeutic Range in Ambulatory Care

ByMarsha A. Raebel, PharmD,Nikki M. Carroll, MS,Susan E. Andrade, ScD,Elizabeth A. Chester, PharmD,Jennifer Elston Lafata, PhD,Adrianne Feldstein, MD,Margaret J. Gunter, PhD,Winnie W. Nelson, PharmD,Steven R. Simon, MD, MPH,K. Arnold Chan, MD, ScD,Robert L. Davis, MD, MPH,Richard Platt, MD

May 1st 2006

Health Plan Members' Views on Forgiving Medical Errors

ByKathleen M. Mazor, EdD,Steven R. Simon, MD,Robert A. Yood, MD,Brian C. Martinson, PhD,Margaret J. Gunter, PhD,George W. Reed, PhD,Jerry H. Gurwitz, MD

January 15th 2005

Measuring Patient Safety in Ambulatory Care: Potential for Identifying Medical Group Drug"Drug Interaction Rates Using Claims Data

ByLeif I. Solberg, MD,Judith S. Hurley, MS, RD,Melissa H. Roberts, MS,Winnie W. Nelson, PharmD, MS,Floyd J. Frost, PhD,A. Lauren Crain, PhD,Margaret J. Gunter, PhD,Linda R. Young, PharmD

November 1st 2004

The Role of the ECHO Model in Outcomes Research and Clinical Practice Improvement

ByMargaret J. Gunter, PhD

April 1st 1999

Latest Updated Articles

Measuring Patient Safety in Ambulatory Care: Potential for Identifying Medical Group Drug"Drug Interaction Rates Using Claims Data
November 1st 2004
Colorectal Cancer Screening Use Among Insured Primary Care Patients
July 13th 2011
Monitoring of Drugs With a Narrow Therapeutic Range in Ambulatory Care
May 1st 2006
Health Plan Members' Views on Forgiving Medical Errors
January 15th 2005
The Role of the ECHO Model in Outcomes Research and Clinical Practice Improvement
April 1st 1999

Margaret J. Gunter, PhD

Articles by Margaret J. Gunter, PhD

Colorectal Cancer Screening Use Among Insured Primary Care Patients

Monitoring of Drugs With a Narrow Therapeutic Range in Ambulatory Care

Health Plan Members' Views on Forgiving Medical Errors

Measuring Patient Safety in Ambulatory Care: Potential for Identifying Medical Group Drug"Drug Interaction Rates Using Claims Data

The Role of the ECHO Model in Outcomes Research and Clinical Practice Improvement

Latest Updated Articles

Trending on AJMC

Legend Biotech’s CAR T-cell Therapy Shows Early Promise in SCLC, Other Tumors

Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly

Social Factors May Match, Outpace Genetic Risk in Disease Prediction

Long-Term, Consistent Resistance Training Linked to Substantially Lower Type 2 Diabetes Risk

A Case for SGLT2 Inhibitors in Non-Diabetic CKD: Sandra Chaparro, MD

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Margaret J. Gunter, PhD

Articles by Margaret J. Gunter, PhD

Colorectal Cancer Screening Use Among Insured Primary Care Patients

Monitoring of Drugs With a Narrow Therapeutic Range in Ambulatory Care

Health Plan Members' Views on Forgiving Medical Errors

Measuring Patient Safety in Ambulatory Care: Potential for Identifying Medical Group Drug"Drug Interaction Rates Using Claims Data

The Role of the ECHO Model in Outcomes Research and Clinical Practice Improvement

Latest Updated Articles

Trending on AJMC

Legend Biotech’s CAR T-cell Therapy Shows Early Promise in SCLC, Other Tumors

Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly

Social Factors May Match, Outpace Genetic Risk in Disease Prediction

Long-Term, Consistent Resistance Training Linked to Substantially Lower Type 2 Diabetes Risk

A Case for SGLT2 Inhibitors in Non-Diabetic CKD: Sandra Chaparro, MD